Nuvation Bio (NUVB) News Today

$3.30
-0.06 (-1.78%)
(As of 05/14/2024 ET)
Nuvation Bio Inc (NUVB)
Nuvation Bio (NYSE:NUVB) Shares Gap Up to $2.68
Nuvation Bio (NYSE:NUVB) Shares Gap Up to $2.68
Nuvation Bio (NYSE:NUVB) Stock Price Up 5%
Nuvation Bio (NYSE:NUVB) Shares Up 5%
Nuvation Bio (NYSE:NUVB) Price Target Raised to $5.00 at Royal Bank of Canada
Royal Bank of Canada boosted their target price on Nuvation Bio from $4.00 to $5.00 and gave the stock an "outperform" rating in a research report on Wednesday.
Nuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst Upgrade
Nuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst Upgrade
Nuvation Bio (NYSE:NUVB) Trading 3.9% Higher
Nuvation Bio (NYSE:NUVB) Trading Up 3.9%
Nuvation Bio (NYSE:NUVB) Trading Down 8.4%
Nuvation Bio (NYSE:NUVB) Shares Down 8.4%
Assenagon Asset Management S.A. Has $1.12 Million Position in Nuvation Bio Inc. (NYSE:NUVB)
Assenagon Asset Management S.A. raised its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 219.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 738,831 shares of the company's stock after purchasing an additional 507,452
Nuvation Bio (NYSE:NUVB) Shares Down 6.5%
Nuvation Bio (NYSE:NUVB) Shares Down 6.5%
Nuvation Bio (NYSE:NUVB) Sees Unusually-High Trading Volume Following Analyst Upgrade
Nuvation Bio (NYSE:NUVB) Sees Large Volume Increase on Analyst Upgrade
Nuvation Bio (NYSE:NUVB) PT Raised to $8.00 at HC Wainwright
HC Wainwright raised their price target on shares of Nuvation Bio from $5.00 to $8.00 and gave the stock a "buy" rating in a research note on Thursday.
Q2 2024 EPS Estimates for Nuvation Bio Inc. Increased by Wedbush (NYSE:NUVB)
Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Investment analysts at Wedbush lifted their Q2 2024 earnings estimates for shares of Nuvation Bio in a report issued on Monday, March 25th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.05) for the qu
Nuvation Bio (NYSE:NUVB) Shares Gap Up to $2.88
Nuvation Bio (NYSE:NUVB) Shares Gap Up to $2.88
Nuvation Bio (NYSE:NUVB) Upgraded at Jefferies Financial Group
Jefferies Financial Group raised shares of Nuvation Bio from a "hold" rating to a "buy" rating and boosted their target price for the stock from $1.40 to $10.00 in a research report on Wednesday.
Nuvation Bio (NYSE:NUVB) Reaches New 12-Month High at $2.65
Nuvation Bio (NYSE:NUVB) Sets New 1-Year High at $2.65
BTIG Research Upgrades Nuvation Bio (NYSE:NUVB) to Buy
BTIG Research raised shares of Nuvation Bio from a "neutral" rating to a "buy" rating and set a $5.00 price objective on the stock in a research report on Tuesday.
Nuvation Bio (NYSE:NUVB) Shares Gap Down to $2.31
Nuvation Bio (NYSE:NUVB) Shares Gap Down to $2.31
Nuvation Bio (NYSE:NUVB) Shares Up 5.1%
Nuvation Bio (NYSE:NUVB) Trading Up 5.1%
NUVB Apr 2024 2.000 put
NUVB Apr 2024 0.500 call
Nuvation Bio Inc. Expected to Earn Q1 2024 Earnings of ($0.09) Per Share (NYSE:NUVB)
Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Equities researchers at HC Wainwright boosted their Q1 2024 earnings per share (EPS) estimates for shares of Nuvation Bio in a report released on Thursday, March 7th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings o
Nuvation Bio (NYSE:NUVB) Reaches New 12-Month High After Analyst Upgrade
Nuvation Bio (NYSE:NUVB) Reaches New 52-Week High on Analyst Upgrade
HC Wainwright Increases Nuvation Bio (NYSE:NUVB) Price Target to $5.00
HC Wainwright boosted their target price on shares of Nuvation Bio from $4.50 to $5.00 and gave the stock a "buy" rating in a research report on Thursday.
Nuvation Bio (NYSE:NUVB) Reaches New 52-Week High at $2.34
Nuvation Bio (NYSE:NUVB) Hits New 12-Month High at $2.34
Nuvation Bio (NYSE:NUVB) Given "Outperform" Rating at Wedbush
Wedbush reaffirmed an "outperform" rating and issued a $5.00 price objective on shares of Nuvation Bio in a research note on Friday.
Short Interest in Nuvation Bio Inc. (NYSE:NUVB) Declines By 16.7%
Nuvation Bio Inc. (NYSE:NUVB - Get Free Report) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 2,200,000 shares, a decline of 16.7% from the November 30th total of 2,640,000 shares. Approximately 1.5% of the shares of the company are short sold. Based on an average trading volume of 1,330,000 shares, the days-to-cover ratio is presently 1.7 days.
Get Nuvation Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter.

Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)

The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.

Get the full story here.

NUVB Media Mentions By Week

NUVB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NUVB
News Sentiment

0.00

0.56

Average
Medical
News Sentiment

NUVB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NUVB Articles
This Week

2

1

NUVB Articles
Average Week

Get Nuvation Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:NUVB) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners